Editorial: Tumor Microenvironment and Resistance to Current Therapies

Targeting AXL can effectively overcome c-Met-induced therapeutic resistance in renal cancer and promote tumor cell death through increased oxidative stress.

Cancer letters·2025

Seasonal influenza vaccines differentially activate and modulate toll-like receptor expression within the tumor microenvironment.

Frontiers in oncology·2024

Assessing Longitudinal Treatment Efficacies and Alterations in Molecular Markers Associated with Glutamatergic Signaling and Immune Checkpoint Inhibitors in a Spontaneous Melanoma Mouse Model.

JID innovations : skin science from molecules to population health·2024

Intratumoral Influenza Vaccine Administration Attenuates Breast Cancer Growth and Restructures the Tumor Microenvironment through Sialic Acid Binding of Vaccine Hemagglutinin.

International journal of molecular sciences·2024

A novel combination therapy with Cabozantinib and Honokiol effectively inhibits c-Met-Nrf2-induced renal tumor growth through increased oxidative stress.

Redox biology·2023

Attenuated Dengue virus PV001-DV induces oncolytic tumor cell death and potent immune responses.

Journal of translational medicine·2023

MCL-1 as a tumor microenvironment-linked survival node in cholangiocarcinoma.

Frontiers in oncology·2026

Decoding the role of exosomes in bladder cancer: focusing on tumor progression and immune microenvironment modulation.

Frontiers in oncology·2026

A narrative review of in vitro studies on the role of reactive oxygen species in aggravating high-grade serous ovarian cancer development.

Frontiers in oncology·2026

Multimodal AI in high-grade serous ovarian cancer: integrated prediction and clinical decision-making.

Frontiers in oncology·2026

The research progress of the synergistic effect of Epstein-Barr virus and Helicobacter pylori infection in the occurrence and development of gastric cancer.

Frontiers in oncology·2026

Integrating cryoablation with immunotherapy in non-small cell lung cancer: mechanisms, clinical evidence, and translational barriers.

Frontiers in oncology·2026

Reframing kidney outcomes in CKD trials: eGFR slopes, competing risks, and pragmatic trial design.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026

Efficacy and safety of carboplatin-containing chemotherapy in triple-negative breast cancer: A comprehensive systematic review, meta-analysis, and trial sequential analysis with BRCA/HRD subgroup assessment.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2026

Roles of TIR domain-containing adaptor protein in tumor: Inflammation and immune regulation via toll-like receptor signaling.

The Journal of international medical research·2026

Design, Synthesis, and Evaluation of Alkoxyamine Anticancer Prodrugs Bearing Galactoside as an Enzyme-Activated Trigger.

Chemical research in toxicology·2026

The Dual Role of DNA Cross-linking Agents: From Genotoxicity to cGAS-STING-Mediated Immune Activation.

Chemical research in toxicology·2026

High-Resolution Mass Spectrometric Analysis of Selected DNA Adducts in Smokeless Tobacco Users' Oral Cells.

Chemical research in toxicology·2026

Related Experiment Videos

Editorial: Tumor Microenvironment and Resistance to Current Therapies

Related Concept Videos

Targeting AXL can effectively overcome c-Met-induced therapeutic resistance in renal cancer and promote tumor cell death through increased oxidative stress.

Seasonal influenza vaccines differentially activate and modulate toll-like receptor expression within the tumor microenvironment.

Assessing Longitudinal Treatment Efficacies and Alterations in Molecular Markers Associated with Glutamatergic Signaling and Immune Checkpoint Inhibitors in a Spontaneous Melanoma Mouse Model.

Intratumoral Influenza Vaccine Administration Attenuates Breast Cancer Growth and Restructures the Tumor Microenvironment through Sialic Acid Binding of Vaccine Hemagglutinin.

A novel combination therapy with Cabozantinib and Honokiol effectively inhibits c-Met-Nrf2-induced renal tumor growth through increased oxidative stress.

Attenuated Dengue virus PV001-DV induces oncolytic tumor cell death and potent immune responses.

MCL-1 as a tumor microenvironment-linked survival node in cholangiocarcinoma.

Decoding the role of exosomes in bladder cancer: focusing on tumor progression and immune microenvironment modulation.

A narrative review of in vitro studies on the role of reactive oxygen species in aggravating high-grade serous ovarian cancer development.

Multimodal AI in high-grade serous ovarian cancer: integrated prediction and clinical decision-making.

The research progress of the synergistic effect of Epstein-Barr virus and Helicobacter pylori infection in the occurrence and development of gastric cancer.

Integrating cryoablation with immunotherapy in non-small cell lung cancer: mechanisms, clinical evidence, and translational barriers.

Reframing kidney outcomes in CKD trials: eGFR slopes, competing risks, and pragmatic trial design.

Efficacy and safety of carboplatin-containing chemotherapy in triple-negative breast cancer: A comprehensive systematic review, meta-analysis, and trial sequential analysis with BRCA/HRD subgroup assessment.

Roles of TIR domain-containing adaptor protein in tumor: Inflammation and immune regulation via toll-like receptor signaling.

Design, Synthesis, and Evaluation of Alkoxyamine Anticancer Prodrugs Bearing Galactoside as an Enzyme-Activated Trigger.

The Dual Role of DNA Cross-linking Agents: From Genotoxicity to cGAS-STING-Mediated Immune Activation.

High-Resolution Mass Spectrometric Analysis of Selected DNA Adducts in Smokeless Tobacco Users' Oral Cells.

Related Experiment Videos

Editorial: Tumor Microenvironment and Resistance to Current Therapies

Related Concept Videos

Related Articles